132 related articles for article (PubMed ID: 10900162)
41. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
42. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
43. Circulating immune complex concentrations in selected cases of skin disease in dogs.
DeBoer DJ; Ihrke PJ; Stannard AA
Am J Vet Res; 1988 Feb; 49(2):143-6. PubMed ID: 3348525
[TBL] [Abstract][Full Text] [Related]
44. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
[TBL] [Abstract][Full Text] [Related]
45. The location of binding sites on C1q for DNA.
Uwatoko S; Mannik M
J Immunol; 1990 May; 144(9):3484-8. PubMed ID: 2329279
[TBL] [Abstract][Full Text] [Related]
46. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
47. C1q augments platelet activation in response to aggregated Ig.
Peerschke EI; Ghebrehiwet B
J Immunol; 1997 Dec; 159(11):5594-8. PubMed ID: 9548501
[TBL] [Abstract][Full Text] [Related]
48. Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.
Boumba VA; Seferiadis K
J Pept Sci; 2002 Dec; 8(12):683-94. PubMed ID: 12523645
[TBL] [Abstract][Full Text] [Related]
49. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
50. Flow cytometric determination of circulating immune complexes with the indirect granulocyte phagocytosis test.
Terstappen LW; de Grooth BG; Nolten GM; ten Napel CH; van Berkel W; Greve J
Cytometry; 1985 Jul; 6(4):316-20. PubMed ID: 4017797
[TBL] [Abstract][Full Text] [Related]
51. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
[TBL] [Abstract][Full Text] [Related]
52. [Reduced phagocytosis of heat-aggregated human IgG by polymorphonuclear leucocytes from patients with systemic lupus erythematosus (author's transl)].
Ikebe K; Okawa M; Aotsuka S; Yokohari R
Ryumachi; 1980 Apr; 20(2):75-81. PubMed ID: 7384948
[No Abstract] [Full Text] [Related]
53. Determination of ligand binding capacity of soluble Fc gamma RII and Fc gamma RIII in sera of patients with SLE.
Csipo I; Barath S; Kiss E; Szucs G; Szegedi G; Kavai M
Autoimmunity; 2007 May; 40(3):165-8. PubMed ID: 17453714
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
55. T cell autoimmunity to histones and nucleosomes is a latent property of the normal immune system.
Andreassen K; Bendiksen S; Kjeldsen E; Van Ghelue M; Moens U; Arnesen E; Rekvig OP
Arthritis Rheum; 2002 May; 46(5):1270-81. PubMed ID: 12115233
[TBL] [Abstract][Full Text] [Related]
56. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
57. The effect of a protein meal on three fluid-phase assays for circulating immune complexes.
Elkon KB; Lanham JG; Dash AC; Hughes GR
Clin Exp Immunol; 1981 Aug; 45(2):279-82. PubMed ID: 6976243
[TBL] [Abstract][Full Text] [Related]
58. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
59. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
60. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
